Earnings call transcripts

Earnings call transcripts with speakers and Q&A, usually within hours. Each one comes with a summary, the guidance management gave, and what analysts pressed on, free to read.

3,386 transcripts · 1,619 companiesHow to read a callBy API: the earnings call transcripts API.

Older calls

Page 22 of 283 · 3,386 calls

  • Nexpoint Diversified Real Estate Trust (NXDT) Q2 2026 earnings call

    Management framed accelerating buybacks, asset monetization, and operational improvements as the primary routes to narrowing NXDT’s discount.

    Sep 24, 2026Positive0.65
  • Fuller H B (FUL) Q3 2026 earnings call

    Management framed the quarter as evidence that pricing and restructuring can expand margins despite choppy demand, while highlighting Quantum Leap and deleveraging as key execution priorities.

    Sep 24, 2026Positive0.62
  • TD Synnex (SNX) Q3 2026 earnings call

    Management framed the quarter as broad-based growth requiring front-loaded Hyve investment, with AI infrastructure demand and improving future cash conversion underpinning cautious optimism.

    Sep 24, 2026Confident0.72
  • Darden Restaurants (DRI) Q1 2027 earnings call

    Management framed the quarter as resilient execution, with improving traffic, strong brand momentum, and external headwinds largely embedded in unchanged outlook.

    Sep 24, 2026Confident0.78
  • AtlasClear Holdings (ATCH) Q4 2026 earnings call

    Management framed the call around operating leverage from onboarding and diversification, while keeping transaction timing, correspondent economics, and capital plans deliberately unquantified.

    Sep 24, 2026Positive0.50
  • Uxin (UXIN) Q2 2026 earnings call

    Management framed the quarter as a period of market-driven margin pressure followed by faster inventory turnover and improving per-unit profitability.

    Sep 24, 2026Positive0.55
  • Pasqal Holding (PSQLW) FY 2026 earnings call

    Management framed the first public-company call around commercializing deployed neutral-atom systems now while building toward fault-tolerant computing on the same platform.

    Sep 24, 2026Confident0.72
  • Kyverna Therapeutics (KYTX) trial results, September 23, 2026

    Management framed the one-year data as strengthening MIF-CEL’s durability, safety, and regulatory case while keeping commercial readiness on track.

    Sep 24, 2026Confident0.86
  • Stitch Fix (SFIX) Q4 2026 earnings call

    Management framed FY26 as a successful transformation year, but FY27 begins with consumer and acquisition headwinds delaying client growth.

    Sep 23, 2026Positive0.48
  • Cintas (CTAS) Q1 2027 earnings call

    Management framed the raised outlook around improving volume across new customers, retention and cross-selling, while warning that quarterly growth and margins will vary.

    Sep 23, 2026Confident0.78
  • Paychex (PAYX) Q1 2027 earnings call

    Management framed the quarter as strong execution in advisory-led growth and AI productivity, while emphasizing that faster PEO growth shifted revenue mix from management solutions.

    Sep 23, 2026Positive0.68
  • General Mills (GIS) Q1 2027 earnings call

    Management emphasized improving brand execution and share momentum while acknowledging inflation, promotional sensitivity, and pet-food challenges remain unresolved.

    Sep 23, 2026Positive0.45

Companies covered

1,619 companies

154 more under A